

| Package | Price per Dose | Price | |
|---|---|---|---|
| 182 pills | €5,55 | €1.010,93 Free shipping | |
| 120 pills | €6,05 | €726,41 Free shipping | |
| 90 pills | €6,17 | €555,40 Free shipping | |
| 60 pills | €6,86 | €411,63 Free shipping | |
| 30 pills | €7,61 | €228,51 Free shipping | |
| 10 pills | €9,53 | €95,33 |
Please note: This page provides general information about Lamisil (terbinafine) for residents in the Netherlands. It does not replace professional medical advice. Always follow the instructions of your healthcare provider and the information on the product leaflet.
Lamisil is the brand name for terbinafine, an antifungal medicine used to treat certain fungal infections of the skin and nails. It helps clear infections caused by common fungi that affect the skin and nails. In the Netherlands, the availability of Lamisil products may depend on local regulations and may require a prescription for some forms. Your pharmacist or doctor can confirm the exact rules in your situation.
Lamisil is available in different forms, including topical preparations such as creams and solutions, and in oral tablet form. The form prescribed depends on the site and severity of the infection. The topical form is commonly used on the skin, while the oral form is used for more widespread or persistent infections or for some nail infections as advised by a clinician. Always use the medicine exactly as instructed on the packaging or by your healthcare professional.
The active ingredient in Lamisil, terbinafine, works by targeting a key enzyme in fungi. This enzyme is necessary for making a component of the fungal cell membrane. By interfering with this process, fungal growth is slowed or stopped, allowing the body's natural defenses to clear the infection. The medicine acts specifically on fungi and is not effective against viral or bacterial infections.
As with any medicine, Lamisil may cause side effects or interact with other medicines. If you notice anything unusual or feel unwell after starting treatment, contact your healthcare professional. Do not use more than the advised amount and do not stop suddenly without medical guidance. If you have concerns about suitability during pregnancy or breastfeeding, speak with a clinician before starting treatment.
Lamisil cream or solution is commonly used to treat fungal infections of the skin, including athlete’s foot (tinea pedis), ringworm of the body (tinea corporis), and jock itch (tinea cruris). It is designed to kill or inhibit the growth of the fungi responsible for these infections on the surface of the skin.
Oral terbinafine tablets are prescribed for more extensive skin infections or for certain fungal nail infections (onychomycosis) when topical treatment alone is unlikely to be effective. Systemic treatment often requires longer courses and careful monitoring by a healthcare professional. The decision to use an oral form takes into account the infection location, severity, and your overall health.
Lamisil is not suitable for treating all fungal infections or other skin conditions. It does not treat infections caused by bacteria or viruses, and it is not effective against all types of fungi. A clinician will confirm the diagnosis before starting therapy to ensure that Lamisil is appropriate for you.
In all cases, the goal is to clear the infection and relieve symptoms such as itching, scaling, cracking, or discomfort. If you have questions about whether Lamisil is the right choice for your infection, discuss this with your pharmacist or doctor. They can explain the expected outcomes and the plan if the infection does not improve.
Terbinafine works by inhibiting an enzyme in fungi called squalene epoxidase. This enzyme is part of the pathway that makes ergosterol, an essential component of the fungal cell membrane. When ergosterol production is disrupted, the fungal cell membrane becomes damaged and the fungus cannot grow normally.
The reduction in ergosterol also leads to a buildup of squalene inside fungal cells, which can contribute to fungal cell damage and death. Because fungi rely on this pathway, terbinafine is selectively toxic to fungal cells and has limited effects on human cells when used as directed and under medical supervision.
Topical forms deliver the medicine directly to the skin surface where the infection is located, helping to limit exposure to other parts of the body. Oral forms distribute systemically and can reach infected nails or deeper skin layers, which may require longer treatment and closer monitoring. The exact effect and how quickly you see improvements depend on the infection type, location, and treatment form chosen by your clinician.
Your clinician may adjust expectations based on the infection being treated and your response to therapy. If you do not notice improvement after a reasonable period, or if symptoms worsen, contact your healthcare professional for advice. Do not alter treatment on your own without medical guidance.
Always follow the directions provided by your doctor or the product leaflet. The information below is general and may not apply to your specific situation. If you have any doubts, speak with your pharmacist or clinician before starting or continuing treatment.
For topical use, clean and dry the affected area before applying a thin layer of Lamisil to the skin. Apply the medicine as directed, usually once or twice a day, and continue for the full course prescribed even if symptoms improve. Do not cover treated areas with tight bandages or dressings unless advised by a clinician. Avoid applying to healthy skin and avoid contact with the eyes, nose, and mouth.
For oral tablets, take the medicine exactly as prescribed by your clinician. Do not chew or crush tablets unless instructed. Take each dose with a full glass of water. If you forget a dose, contact your clinician for advice on whether to take it as soon as you remember or to skip it. Do not double the next dose to catch up unless directed.
General safety considerations include keeping the skin clean and dry where the topical medicine is applied, washing hands before and after application, and avoiding mixing the medicine with other topical products unless advised. If you experience skin irritation, redness, or an allergic reaction after applying Lamisil, stop use and seek medical advice. If you have any concerns about drug interactions or specific activities (such as wearing contact lenses, swimming, or heavy sweating), ask your healthcare professional for guidance.
Do not use Lamisil if you know you are allergic to terbinafine or any of the ingredients in the product. Allergic reactions can include skin rash, itching, swelling, or trouble breathing; seek immediate medical help if these occur.
People with liver disease or a history of liver problems should inform their clinician before starting terbinafine. Liver injury is a rare but serious concern with oral terbinafine, and liver function may be monitored during treatment when appropriate.
Pregnant or breastfeeding individuals should discuss Lamisil with a healthcare professional before starting treatment. The use of terbinafine during pregnancy or while breastfeeding may not be recommended in all cases, and alternatives may be considered based on the health needs of both mother and baby.
Tell your clinician about all medicines you take, including prescription, over-the-counter products, and herbal or complementary medicines. Some medicines can interact with terbinafine, affecting how either medicine works or increasing the risk of side effects. Your clinician can assess potential interactions and adjust treatment if needed.
Topical Lamisil is generally well tolerated, but some people may experience local skin irritation, itching, or a burning sensation at the site of application. If these symptoms persist or worsen, contact your pharmacist or clinician for advice.
Oral terbinafine can affect the liver. Signs of possible liver problems include yellowing of the skin or eyes, dark urine, persistent abdominal pain, or unusual fatigue. If any of these occur, seek urgent medical advice and discontinue use until assessed by a clinician.
Serious skin reactions are possible, though rare. Seek medical help promptly if you notice a widespread rash, blistering, peeling, or mucous membrane involvement. Stopping the medicine may be advised while a clinician evaluates the reaction.
Do not use different antifungal products at the same time unless advised by a clinician. If you have broken or irritated skin, avoid applying the product there unless directed to do so. If you experience symptoms such as swelling of the face or lips, these may indicate a more serious reaction and require urgent medical attention.
Common side effects with topical Lamisil include mild itching, redness, or a burning sensation at the application site. These usually improve with continued use or after stopping the treatment.
Common side effects with oral terbinafine can include stomach upset, flatulence, headache, or a skin rash. If you notice a persistent rash or swelling, contact a clinician.
Some people report changes in taste or a temporary loss of taste during or after treatment with oral terbinafine. If this lasts, inform your healthcare provider.
Serious but rare side effects may include signs of liver problems, severe allergic reactions, or severe skin reactions. If you experience any of these, seek urgent medical help and stop taking the medicine until evaluated by a clinician.
Terbinafine can interact with other medicines. It is important to tell your pharmacist about all medicines you take, including any that are over the counter or herbal products. Some combinations may require monitoring or dose adjustments.
Your clinician may decide to adjust treatment if interactions are likely to increase the risk of adverse effects or reduce effectiveness. Do not start or stop medicines without professional advice.
If you are taking medicines that affect the liver or that are metabolized by the liver, your clinician may perform extra checks or adjust the plan. Always report any new medicines to your healthcare provider during treatment with Lamisil.
Alcohol use, certain supplements, and other substances can influence liver function or interact with antifungal therapy. Discuss lifestyle and supplement use with your clinician to minimize potential risks.
Pregnant individuals should not start Lamisil without consulting a healthcare professional. The safety of terbinafine during pregnancy has not been established for all infection types, and alternatives may be considered depending on the infection and clinical need.
If you become pregnant while using Lamisil, inform your clinician promptly. They can advise on whether to continue treatment and whether a different approach is more appropriate for you and the fetus.
Breastfeeding while using Lamisil should be discussed with a healthcare professional. Terbinafine can pass into breast milk, and the potential effects on a nursing infant should be considered when deciding on treatment.
In all cases, treatment decisions during pregnancy or lactation should be guided by a clinician who can weigh benefits and risks and consider alternative options if needed.
The availability of Lamisil products may depend on local rules and the form of the medicine. Some topical formulations might be sold in pharmacies with pharmacist guidance, while others may require a prescription. Check with your pharmacist or doctor to confirm what applies to you.
Most people begin to notice improvement within a few weeks of starting treatment, especially for skin infections. Nail infections can take longer to show clear improvement and may require continued therapy as advised by your clinician. If there is no improvement after several weeks, contact your healthcare professional for advice.
If you miss a topical application, apply it as soon as you remember and resume the regular schedule if it is still within the same day. If you miss an oral dose, follow the guidance given by your clinician or the packaging insert. Do not double the next dose to catch up unless advised.
Using multiple antifungal treatments together is not usually recommended without advice from a clinician. If you are switching therapies or combining products, discuss this with your pharmacist to avoid potential interactions or skin irritation.
Contact a clinician if you experience severe skin reactions, signs of liver problems (for example, yellowing of the skin or eyes, dark urine, persistent abdominal pain), a fever, or if there is no improvement after a reasonable period. Also seek advice if your symptoms worsen or spread.
Safety and dosing in children depend on age, weight, and the type of infection. The clinician will determine whether Lamisil is appropriate for a child and which form to use. Always use medicines approved for pediatric use and follow the clinician’s instructions.
Moderation is generally advised when taking medicines that can affect the liver. If you have concerns about alcohol use and Lamisil, discuss them with your clinician, especially if you are taking the oral form that is processed by the liver.
Fungal infections can recur. If symptoms return after completing therapy, see your clinician for a reassessment. A different treatment plan or a longer course may be recommended based on the infection and its location.
Store Lamisil as indicated on the packaging or by your pharmacist. Keep medicines out of reach of children. Do not use expired products, and protect from moisture and heat if required by the form you have.
Taste changes have been reported with some systemic antifungal medicines, including terbinafine in rare cases. If you notice persistent changes in taste or mouth symptoms, inform your clinician. They can determine whether this is related to the medicine and advise on next steps.
Patient information for Lamisil typically comes from the product leaflet provided by the manufacturer, as well as standard medical references used in Dutch pharmacy practice. Additional guidance may be drawn from national pharmaceutical guidelines and regulatory bodies that oversee antifungal therapy in the Netherlands. If you have specific questions, your pharmacist or healthcare professional can point you to the official, up-to-date information for your region.
14–21 days. Free from €182,34 .
5–9 days. €27,35
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
